Whitney Hauser
Optometrist · Memphis, TNNPI 1215921085
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Novartis at 35.0% of the total. Reporting peaked in 2019 at $204,555 and has fallen 100.0% since, to $78 in 2023. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 406 payments — averaging $813.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$116K
- Shire North American Group Inc$83K
- Johnson & Johnson Surgical Vision, Inc.$52K
- Alcon$26K
- AbbVie$10K
- Sight Sciences, Inc.$9K
- plus $34K from 17 others
What the payments were for
- Consulting fees$128,92539%
- Speaking & faculty fees$152,51546%
- Travel & lodging$40,73912%
- Food & beverage$8,2713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 129 | $115,788 |
| Shire North American Group Inc | 166 | $83,177 |
| Johnson & Johnson Surgical Vision, Inc. | 11 | $51,748 |
| Alcon | 23 | $26,454 |
| AbbVie | 16 | $10,376 |
| Sight Sciences, Inc. | 12 | $8,923 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $7,320 |
| Sun Pharmaceutical Industries Inc. | 6 | $7,161 |
| Lumenis, Inc | 1 | $6,000 |
| Dompe US, Inc. | 4 | $2,903 |
| Vertical Pharmaceuticals, LLC | 2 | $2,750 |
| Alcon Research LLC | 1 | $2,650 |
| Glaukos Corporation | 4 | $2,010 |
| Kala Pharmaceuticals, Inc. | 5 | $1,182 |
| Lumenis Ltd. | 1 | $1,000 |
| Tearlab Corp | 1 | $500 |
| Amgen | 2 | $149 |
| Carl Zeiss Meditec, Inc. | 2 | $119 |
| Astellas Pharma US Inc | 1 | $78 |
| Quidel Corporation | 2 | $59 |
| Coopervision Inc. | 1 | $54 |
| Staar Surgical Company | 1 | $29 |
| Johnson & Johnson Vision Care, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIIDRA$192,429
- ILUX$12,853
- DAILIES$9,408
- TearCare$8,768
- CEQUA$7,045
- Systane$6,408
- One Series Ultra IOL Delivery System$4,200
- VYZULTA$4,125
- Oxervate$2,868
- BIOTRUE$2,638
- ULTRA$2,638
- iStent Trabecular Micro-Bypass Stent System$2,000
- iStent inject Trabecular Micro-Bypass Stent System$1,500
- INVELTYS$1,100
- TearLab Osmolarity System$500
- ZYLET$400
- CyPass$265
- LUMIGAN$149
- RESTASIS$110
- CIRRUS HD-OCT$105
How this compares
$330,450 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.
Other optometrist in Memphis
- Christopher LievensMemphis$566K
- Melvin FriedmanMemphis$108K
- Desirae BrinkleyMemphis$51K
- Abagail KirkMemphis$14K
- Bradley HinesMemphis$12K
- David EvansMemphis$12K
- Daniel FullerMemphis$8K
- Dennis MathewsMemphis$8K
- Michael GerstnerMemphis$8K
- Laurel RobertsMemphis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.